58 results
424B7
RLAY
Relay Therapeutics Inc
10 Jan 24
Prospectus with selling stockholder info
9:22am
supplement, on a firm commitment basis. This prospectus may be used in connection with any offering of our securities through any of these methods … underwriting agreement with dealers, acting as standby underwriters. We may pay the standby underwriters a commitment fee for the securities
8-K
EX-10.1
RLAY
Relay Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
of the Company to grant, extend or enter into any such option, warrant, call, subscription or other right, agreement, arrangement or commitment. Neither
424B7
RLAY
Relay Therapeutics Inc
16 Nov 23
Prospectus with selling stockholder info
4:16pm
-5836. As a demonstration of our commitment to PI3Kα as a target, we have also developed a second preclinical molecule, RLY-5836, which is a selective … or, if indicated in the applicable prospectus supplement, on a firm commitment basis. This prospectus may be used in connection with any offering of our
8-K
EX-1.1
9nc5ckle5r0 v7
15 Sep 22
Relay Therapeutics Announces Proposed Public Offering of Common Stock
6:33am
424B5
bj5n088wyg
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B5
b0oufbozr3zhdnk
12 Sep 22
Prospectus supplement for primary offering
7:35am
424B7
7fl3vg4jr
1 Sep 22
Prospectus with selling stockholder info
4:06pm
8-K
EX-99.1
njcoagrj2vw4kk 27
27 Jun 22
Regulation FD Disclosure
6:11am
PRE 14A
snk4p
1 Apr 22
Preliminary proxy
4:30pm
8-K
EX-1.1
nr9zc s5dkmucgdqbnv
14 Oct 21
Relay Therapeutics Announces Proposed Public Offering of Common Stock
4:15pm